艾伯维公司 ABBV 深 沪
已收盘 09-25 16:00:00 美东时间
264.34
-0.780
-0.29%
华盛通- 最 高266.00
- 今 开265.49
- 成交量 254.17万股
- 最 低 262.59
- 昨 收 265.12
- 总市值 4671.20亿
- 52周最高 269.39
- 市盈率 静 111.96
- 换手率 0.14%
- 52周最低 189.02
- 委 比 -37.50%
- 总股本 17.67亿
- 历史最高 269.39
- 量 比 0.60
- 振 幅 1.29%
- 历史最低 -22.07
- 每 手 1
- 风险率 18.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ADARx Pharmaceuticals surges following upsized IPO
ADARx Pharmaceuticals (ADRX) closed up ~14% on its first day of trading Friday following an upsized $446.3M IPO. Shares were priced at $17 but opened at $22.10. They closed at $19.35. The upsized IPO ...
09-26 04:11
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
ADARx Pharmaceuticals宣布其扩大后的首次公开发行定价，发行26,250,000股普通股，每股17美元，预计筹资4.463亿美元。承销商有30天期权购买额外3,937,500股。股票将在纳斯达克上市，代码ADRX，9月25日开始交易，9月28日完成发行。AbbVie参与私募，购买约4.9%股份，筹资总额预计5.352亿美元。公司专注于siRNA疗法，治疗多种疾病，并与AbbVie合作开发药物。
09-24 23:33
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
Hemab Therapeutics appoints Keli Walbert to its Board of Directors, effective September 24, 2026. With over 20 years of commercial leadership experience in biopharmaceuticals, Walbert brings expertise in launching therapies for high-unmet-need conditions. Her appointment strengthens Hemab's Board as the company advances its pipeline for treating bleeding disorders. Walbert previously led commercial launches at Horizon Therapeutics, AbbVie, and ot...
09-24 20:01
Vertiv to acquire King Environmental Services to expand liquid cooling capabilities
Vertiv Holdings (VRT) on Thursday said that it has entered into an agreement to acquire King Environmental Services, a Europe-based provider of fluid management, commissioning, and load-testing servic...
09-24 18:37
美股生物科技板块盘前涨跌不一 诺和诺德跌1.00%
每经AI快讯，9月24日，美股生物科技板块盘前涨跌不一，强生跌0.05%，Moderna跌1.70%，诺和诺德跌1.00%，艾伯维涨0.24%，默沙东涨1.9...
09-24 16:11
J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma
A new analysis of phase 3 data found that a combination of Johnson & Johnson's Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase) for multiple myeloma patients who had received...
09-23 22:20
黄仁勋押注的AI制药，要IPO了！
近日，AI药物研发公司Iambic Therapeutics正式向美国证券交易委员会（SEC）公开递交招股书，申请在纳斯达克上市，股票代码"IAM"。此前，公司...
09-23 20:30
siRNA 新锐 ADARx (ADRX.US)启动3.5亿美元 IPO，艾伯维认购4.9%股份、最高出资1亿美元
ADARx 拟募资3.5亿美元登陆纳斯达克，艾伯维最多投资1亿美元认购4.9%股份，中值估值18亿美元。
09-22 15:00
AbbVie gains EU approval for Rinvoq to treat pediatric arthritis
AbbVie (ABBV) on Tuesday said that Rinvoq is now approved in the European Union for the treatment of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have ...
09-22 14:30
